Who Paid My Doc
Illuccix
Drug Prostate Cancer Diagnosis
NDC 74725-100-64
General payments
$2,031,184
Research payments
$280,150
Through program year 2025, $2,031,184 in general payments and $280,150 in research payments were reported against Illuccix (Prostate Cancer Diagnosis).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $727,688 | 3,806 |
| 2024 | General | $704,688 | 2,659 |
| 2024 | Research | $6,200 | 4 |
| 2023 | General | $501,651 | 2,157 |
| 2023 | Research | $19,950 | 9 |
| 2022 | General | $97,157 | 520 |
| 2022 | Research | $254,000 | 31 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 69 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
9,142 general · 44 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.